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Abstract
Partially observed cured data occur in the analysis of spontaneous abortion (SAB)
in observational studies in pregnancy. In contrast to the traditional cured data, such
data has an observable ‘cured’ portion as women who do not abort spontaneously. The
data is also subject to left truncate in addition to right-censoring because women may
enter or withdraw from a study any time during their pregnancy. Left truncation in
particular causes unique bias in the presence of a cured portion. In this paper, we
study a cure rate model and develop a conditional nonparametric maximum likelihood
approach. To tackle the computational challenge we adopt an EM algorithm making
use of “ghost copies” of the data, and a closed form variance estimator is derived. Under
suitable assumptions, we prove the consistency of the resulting estimator involving an
unbounded cumulative baseline hazard function, as well as the asymptotic normality.
Simulation results are carried out to evaluate the finite sample performance. We present
the analysis of the motivating SAB study to illustrate the power of our model addressing
both occurrence and timing of SAB, as compared to existing approaches in practice.
Keywords: Cure rate model, EM algorithm, ghost copy, left truncation, NPMLE,
observable Cure.
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1 Introduction
Our work was motivated by research carried out at the Organization of Teratology
Information Specialists (OTIS), which is a North American network of university or
hospital based teratology services that counsel between 70,000 and 100,000 pregnant
women every year. Research subjects are enrolled from the Teratology Information
Services and through other methods of recruitment, where the mothers and their babies
are followed over time. Phone interviews are conducted through the length of the
pregnancy along with pregnancy diaries recorded by the mother. An outcome phone
interview is conducted shortly after the pregnancy ends, and if it results in a live birth,
a dysmorphology exam is done within six months and with further follow-ups at one
year and possibly later dates. Recently it has been of interest to assess the effects
of medication exposures on spontaneous abortion (SAB) (Xu and Chambers, 2011;
Chambers et al., 2011). Here we examine the OTIS autoimmune disease in pregnancy
database for risk factors as well as effects of medications on spontaneous abortion.
By definition SAB occurs within the first 20 weeks of gestation; any spontaneous
pregnancy loss after that is called still birth. Ultimately we would like to know if an
exposure modifies the risk of SAB for a woman, which may be increased or decreased.
It is known that in the population for clinically recognized pregnancies the rate of SAB
is about 12% (Wilcox et al., 1988). On the other hand, in our database the empirical
SAB rate is consistently lower than 10%. This is due to the fact that women may enter
a study any time before 20 weeks’ gestation. Figure 1 left panel shows the histograms
of study entry times up to 20 weeks of gestation from our autoimmune disease in
pregnancy database. This way women who have early SAB events are less likely to be
captured in our studies, and such selection bias is known as left truncation in survival
analysis. Left truncation has been studied by many authors since the 1980s, and has
attracted much recent attention in the context of length-biased data (Asgharian et al.,
2006; Qin et al., 2011, among others). Figure 1 right panel shows the left truncated
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Kaplan-Meier curve for the SAB event.
As seen from the Kaplan-Meier curve the majority of the pregnant women are free
of SAB; they are considered ‘cured’ in the time-to-event context. Cure rate models are
well studied in the literature for right-censored data. The models effectively analyze
the survival distribution of those who are susceptible along with the probability of an
individual being ‘cured’. In the approaches using mixture models, logistic regression
is often used to model the cured probability. For the dependency of the survival
function on the covariates among the non-cured, various regression models have been
considered: the Cox proportional hazards model (Kuk and Chen, 1992; Sy and Taylor,
2000), transformation models (Lu and Ying, 2004), and richly parametrized models
when the shape of the hazard function is of interest (Hanson et al., 2003). Cure rate
models have also been developed along the lines of non-mixture models (Chen et al.,
1999; Zeng et al., 2006). In addition to right-censored data, cure-rate models have
also been developed for interval-censored data (Kim and Jhun, 2008). To our best
knowledge, however, they have not been considered for truncated data which, unlike
censoring, poses a unique set of challenges. While left truncation has been well studied
in the literature, the challenges are again unique in the presence of a cured portion.
Most importantly, left truncation leads to selection bias that needs to be explicitly
counted for, and in the process of doing so computational challenges also arise, as will
be seen below.
Cure models are used in various biomedical studies where data often include a
substantial portion of ‘long-term’ survivors who are no longer susceptible to the event
of interest (Farewell, 1982, 1986). Our data however, differs from classical cured data
where the ‘long-term’ survivors are never observed to be cured, rather they are censored
at a finite time point (Sy and Taylor, 2000; Lu and Ying, 2004, often taken as the
maximum). In our case, ‘cured’ is defined as surviving 20 weeks of gestation, and we
observe over 80% of our subjects as cured from SAB.
3
In the following we consider the mixture cure rate model. This choice has been made
based on in-depth discussions with our scientific collaborators, because it is important
to understand both the risk factors for SAB (yes/no) as well as the predictors of
timing of SAB events among those who experience them. Different timing of SAB can
reflect different underlying biological processes. In the next section we show that with
many observed ‘cured’ women in our data, a slightly different likelihood than the one
commonly seen in the literature should be used. We discuss computational challenges
with the likelihood, and adopt an EM algorithm using ‘ghost copies’ of the observed
data. In section 3, the resulting estimator is shown to be consistent and asymptotic
normal, despite the fact that the cumulative baseline hazard function diverges at the
finite time point before ‘cure’ is achieved. We illustrate the effectiveness of the method
on finite samples via simulation experiments in section 4. We conclude with the analysis
of SAB data from the OTIS database described above.
2 Model and NPMLE
2.1 Model and partially observed cured data
Let τ < ∞ be a strict upper bound of time for the event of interest, beyond which
a subject is considered cured. In the pregnancy example above, this would be the 20
weeks of gestation. The whole population consists of two subpopulations: cured and
non-cured. Let the binary random variable A indicate whether a subject belongs to
the non-cured subpopulation; and let T ∗ ∈ (0, τ) be the failure time random variable
for this subpopulation. The overall outcome time T is given by the mixture (Lu and
Ying, 2004): T = AT ∗ + (1−A)τ . Let Z1 and Z2 be two covariate vectors; they may
share common covariates depending on the application. We assume that A given Z1
follows the logistic regression model
P (A = 1|Z1,Z2) = p = e
α>Z1
1 + eα>Z1
,
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and that T ∗ given Z2 follows the proportional hazard regression model with cumulative
baseline hazard function λ0(t) =
∫ t
0 λ0(u)du:
P (T ∗ ≥ t|Z2) = S(t|Z2) = exp{−Λ0(t)eβ>Z2}.
Note that Λ0(τ) = +∞ so that S(τ |Z2) = 0.
Our data is subject to left truncation and right-censoring. Let Q be the left
truncation time and C the right-censoring time, satisfying 0 ≤ Q < C; we also as-
sume that they are independent of (A, T ∗) conditioning on Z1 and Z2. For subjecrts
i = 1, ..., n, the observed data include Z1i, Z2i, Qi, Xi = Ti ∧ Ci, δ1i = Ai · I(Ti ≤ Ci),
δ0i = (1 − Ai)I(Ci ≥ τ) and δci = I(Ci < Ti ≤ τ). In other words δ1i is the indicator
that a subject has an observed event (non-cured), δ0i is the indicator that a subject is
observed to be cured, and δci is the indicator that a subject is censored before τ so that
we do not know whether she is cured or not. Note that the subject i is observed only
if Ti > Qi, hence left truncation is known to lead to a biased sample from the popula-
tion. We note again that our data is different from the classical cure model literature,
where the cured individuals are always treated as censored; we refer to our data as
partially observed cured data. Because of right-censoring, Ai may not be observed; but
we emphasize here that we do observe many Ai = 0 in our data.
Denote θ = (α,β,Λ0). For the purposes of nonparametric maximum likelihood
estimation (NPMLE), it is necessary to discretize Λ0 to be Λ0(t) =
∑K
k=1 λkI(t ≥ tk),
where 0 < t1 < · · · < tK < ∞ are the unique failure times (Johansen, 1983; Murphy,
1994). We apply the likelihood approach conditional upon the left truncation time
Qi and the right-censoring time Ci, as no parametric distributional assumptions are
made about these two random variables. Denote pi = e
α>Z1i/(1 + eα
>Z1i), λi(t) =
λ0(t) exp(β
>Z2i), fi(t) = λi(t)Si(t), and Si(t) = exp{−Λ0(t)eβ>Z2i}. The likelihood
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for our observed data is
L(θ) =
n∏
i=1
Li(θ;Xi, δ
1
i , δ
0
i , δ
c
i |Ti > Qi,Z1i,Z2i, Qi, Ci)
=
n∏
i=1
{
piλi(Xi)Si(Xi)
}δ1i (1− pi)δ0i {1− pi + piSi(Xi)}δci
1− pi + piSi(Qi) , (1)
where 1− pi + piSi(Xi) = P (Ti > Qi).
2.2 NPMLE through EM
Complete data likelihood
The complexity of observed likelihood (1) leads to the challenge of optimization. To
reduce the problem we follow the approach of Vardi (1985), rediscovered recently by
Qin et al. (2011).
To augment the observed data, we first note that the group indicator Ai is latent
whenever censoring occurs. In addition, we compensate for the left truncation through
the “ghost copy” algorithm proposed in Qin et al. (2011). For each observed subject
with the pair of covariates (Z1i,Z2i) and entry time Qi, there are Mi hypothetical
“truncated samples” with latent event time T˜ij < Qi, j = 1, ...,Mi. The resulting
complete likelihood is
Lc(θ) =
n∏
i=1
{
piλi(Xi)Si(Xi)
}δ1i (1− pi)δ0i {piSi(X)}Aiδci (1− pi)(1−Ai)δci
× pMii
Mi∏
j=1
∏
k:tk≤Qi
{
λke
β>Z2iSi(tk)
}I(T˜ij=tk) (2)
In this way, the two sets of parameters α and β are separated in the complete data
likelihood. All remaining product terms are those in the usual likelihoods for the
logistic and the Cox regression model. Consequently, the M-step update is instantly
available from existing solvers.
Given the observed data O, it can be seen that for subject i who is censored at
Xi, the unobserved group indicator Ai follows Bernoulli distribution with P (Ai = 1) =
6
piSi(Xi)/{1 − pi + piSi(Xi)}. For a subject with truncation time Qi and covariates
(Z1i,Z2i), it can be seen that the number of truncated “ghost” copies Mi follows
the geometric distribution with probability P (Ti < Qi) = pi{1 − Si(Qi)}. For the
“ghost” event times let T˜ij be one of the observed event times tk < Qi with probability
proportional to fi(tk) = λke
β>Z2iSi(tk):
P (T˜ij = tk|Mi,O) = I(tk ≤ Qi)λke
β>Z2iSi(tk)∑
k:tk≤Q λke
β>Z2iSi(tk)
. (3)
By restricting the “ghost” event times to the observed event times, we are able to exploit
the convenience of directly applying the weighted Cox regression later. The price we
pay is a slight discrepancy between
∑
k:tk≤Q λke
β>Z2iSi(tk) and 1−Si(Qi). Integrating
out the latent variables in Lc(θ) does not give exactly the observed likelihood L(θ).
However, we show later that this difference is asymptotically negligible so that the
solution from the above EM is asymptotically equivalent to the true NPMLE.
The EM Algorithm
From (2) we can write the complete data log-likelihood lc = logLc as
lc(α,β,λ) =
n∑
i=1
[
δ1iAi
K∑
k=1
I{Xi = tk} log fi(tk) +Mi
∑
k:tk<Qi
I{T˜i = tk} log fi(tk)
+ (1− δ1i )Ai logSi(Xi) + (1−Ai) log(1− pi) + (Ai +Mi) log(pi)
]
, (4)
where λ = (λ1, ..., λK).
Though the algorithm runs stably from any initial values of the parameters in the
support, we recommend to fit a na¨ıve logistic regression without censored subjects for
α(0) and a na¨ıve Cox regression for β(0) and λ(0) treating the observed cured subjects
as censored at τ , to minimize the number of iterations until convergence.
E-step
At the (l + 1)-th iteration (l = 0, 1, ...), let α(l),β(l),λ(l) be the parameter values
at the current iteration upon which p
(l)
i , f
(l)
i and S
(l)
i are defined. The distributions
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of the latent variables conditioning on the observed data are given in the above, and
their conditional expectations can be computed as
E[I{T˜ij = tk}|Mi,O;α(l),β(l),λ(l)] = I(tk < Qi)f
(l)
i (tk)∑
h:th<Qi
f
(l)
i (th)
, (5)
E[Mi|O;α(l),β(l),λ(l)] =
p
(l)
i
∑
k:tk<Qi
f
(l)
i (tk)
1− p(l)i
∑
k:tk<Qi
f
(l)
i (tk)
, (6)
E[Ai|O;α(l),β(l),λ(l)] = δ1i + δci
p
(l)
i S
(l)
i (Xi)
1− p(l)i + p(l)i S(l)i (Xi)
. (7)
Since the latent variables all enter linearly into the complete data log-likelihood, the
expected complete data log-likelihood is
E(lc|O) =
n∑
i=1
K∑
k=1
{
wfi,k log fi(tk) + w
S
i logSi(Xi) + w
p
0,i log(1− pi) + wp1,i log(pi)
}
,
(8)
where the weights are computed as
wfi,k = δ
1
i I{Xi = tk}+
p
(l)
i f
(l)
i (tk)
1− p(l)i
∑
h:th<Qi
f
(l)
i (th)
I{tk < Qi},
wSi = δ
c
i
p
(l)
i S
(l)
i (Xi)
1− p(l)i + p(l)i S(l)i (Xi)
,
wp0,i = δ
0
i + δ
c
i
1− p(l)i
1− p(l)i + p(l)i S(l)i (Xi)
,
wp1,i = δ
1
iAi + δ
c
i
p
(l)
i S
(l)
i (Xi)
1− p(l)i + p(l)i S(l)i (Xi)
+
p
(l)
i
∑
k:tk<Qi
f
(l)
i (tk)
1− p(l)i
∑
k:tk<Qi
f
(l)
i (tk)
.
M-step
From (8) the expected log-likelihood can be written as the sum of two parts, so
that the M-step can be achieved using a weighted logistic regression optimized over α:
lglm =
n∑
i=1
wp0,i log(1− pi) + wp1,i log(pi);
and a weighted Cox proportional hazard regression optimized over β:
lcoxph =
n∑
i=1
K∑
k=1
wfi,k log fi(tk) +
n∑
i=1
wSi logSi(Xi).
Easily implemented solution is available from existing glm and coxph solvers in R, to
obtain α(l+1), β(l+1) and λ(l+1).
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Variance Estimator
At convergence of the EM algorithm where θˆ denotes the NPMLE, the Louis (1982)
formula can be used to give the observed Fisher information:
Iobs(θˆ) =
n∑
i=1
Eθˆ[Bi|O]−
n∑
i=1
Eθˆ[SiS
>
i |O]− 2
n∑
i<i′
Eθˆ[Si|O]Eθˆ[Si|O]>, (9)
where Si and Bi are the gradient ∇lci and the negatives of Hessian −∇2lci of the com-
plete data log-likelihood. The above is in closed form, and the details are given in
Appendix B. We show in the next section that (9) provides a consistent variance esti-
mator for the NPMLE, and its use in association with the NPMLE has been advocated
in the literature (Vaida and Xu, 2000; Zeng and Lin, 2007; Gamst et al., 2009).
3 Theory
Let θ0 = (α0,β0,Λ0(·)) denote the true parameter value. Following Andersen et al.
(1993), we define the counting process Ni(t) = δ
1
i I(Xi ≤ t) and the at-risk process
Yi(t) = I(Qi ≤ t ≤ Xi). Their sums are denoted as N¯(t) =
∑n
i=1Ni(t), and Y¯ (t) =∑n
i=1 Yi(t). By Doob-Meyer decomposition, a martingale with respect to the filtration
Ft = σ{Ni(u), Yi(u),Z1,Z2, u ≤ t} is
Mi(t) = Ni(t)−
∫ t
0
φθ0i (u)Yi(u)e
β>0 Z2idΛ0(u), (10)
where
φθi (t) =
exp{α>Z1i − Λ(t)eβ>Z2i}
1 + exp{α>Z1i − Λ(t)eβ>Z2i}
= Pθ(Ai = 1|Xi ≥ t). (11)
To make use of the martingale framework, we write the observed log-likelihood ln =
logL, where L(θ) was given in (1), as
ln =
n∑
i=1
∫ τ
0
log
(
φθi (u)e
β>Z2i
)
dNi(u)−
∫ τ
0
Yi(u)φ
θ
i (u)e
β>Z2idΛ(u)
+
∫ τ
0
log
(
∆Λ(u)
)
dNi(u),
9
where ∆Λ(u) is the size of jump of the baseline cumulative hazard at u (Murphy, 1994).
We establish the theory under the following assumptions. The vector norm throughout
this paper is the uniform norm, i.e. the largest absolute value among all elements.
Assumption 1. The true finite-dimensional parameter (α0,β0) is an element of the
interior of a compact set {(α,β) : ‖α‖ ∨ ‖β‖ ≤ D1} for some constant D1.
Assumption 2. The covariates (Z1,Z2) follow distribution FZ(·, ·). They are bounded
a.s.: there exists D2 > 0, such that P (max{‖Z1‖, ‖Z2‖} ≤ D2) = 1. Also, their
covariance matrices Var(Z1)(without intercept term) and Var(Z2) are both positive-
definite. Denote constant m such that
0 < m−1 = e−D1D2 ≤ eα>Z1 ∧ eβ>Z2 ≤ eα>Z1 ∨ eβ>Z2 ≤ eD1D2 = m <∞ a.s.. (12)
Assumption 3. The baseline cumulative hazard function Λ0(t) is a non-decreasing
continuous function on [0, τ). Λ0(0) = 0 and Λ0(τ−) =∞. And
inf
t∈[0,τ ]
E[Y (t)|Z1,Z2] > ε > 0, a.s.. (13)
Assumption 4. There exists ζ ∈ (0, τ) such that P (Q > ζ) = 0. Λ0(t) is strictly
increasing over [0, ζ], and E[Y (t)|Z1,Z2] is Lipschitz continuous w.r.t to Λ0(t) on
[0, ζ] a.s.; that is, there is a constant
L ≥ sup
0≤t<s≤ζ
{ |E[Y (t)|Z1,Z2]− E[Y (s)|Z1,Z2]|
|Λ0(t)− Λ0(s)|
}
, a.s.. (14)
The above Assumption 3 is specifically made for cure rate models with an observable
cured portion. This assumption enforces that the failure time must occur prior to a
well-defined upper bound. Equation (13) requires that certain proportion of subjects
enter the study at time zero. While this may not always be the case for our pregnancy
studies, time zero may be replaced by the earliest entry time into the study and the
inference is conditional upon survival beyond that time, and all the results established
in this section carry over. Assumption 4 gives the regularity conditions on truncation
10
and censoring. The truncation times should be bounded away from time τ ; this is
required in order to establish Lemma 1 below. The truncation-censoring distribution
also has to possess certain level of continuity with respect to the distribution of event
time. For example, the continuity condition is satisfied when the distributions for Q,
C and T given Z1 and Z2 all have densities that are bounded away from ∞ and 0
almost surely. This condition can be weakened to allow Λ0(t) to be constant over some
open set and require only that E[Y (t)|Z1,Z2] is Lipschitz continuous with respect
to Λ0(t) on a open set Ω ⊂ [0, ζ] consisting of finite many open intervals, on which∫
Ω dΛ0 = Λ0(ζ). All theoretical results under this weakened condition can be achieved
by repeatedly applying the steps in the current proof.
For the asymptotic normality we make the following assumption where τ ′ is defined
later.
Assumption 3’. The baseline cumulative hazard Λ0(t) is a non-decreasing continuous
function on [0, τ ′]. Λ0(0) = 0, Λ0(τ ′) <∞ and Λ0(τ−) =∞. And
inf
t∈[0,τ ′]
E[Y (t)|Z1,Z2] > ε > 0, a.s..
3.1 Existence of NPMLE
First, we show the existence of the NPMLE.
Theorem 1. Under Assumptions 1 and 2, if
∑n
i=1Ni(τ) > 0, then a maximizer of
ln(θ), θˆ = (αˆ, βˆ, Λˆ(·)) exists and is finite.
For the proof we use the same technique as in Murphy (1994). All the proofs are in
Appendix A.
We now show that the solution from the previously described EM algorithm is
asymptotically equivalent to the NPMLE.
Lemma 1. Let θ˜ be the solution from the EM algorithm with complete data likelihood
(2) and θˆ be the NPMLE for the observed likelihood (1). Under Assumptions 1 - 4,
11
n−1{ln(θˆ)− ln(θ˜)} = Op(1/n).
Theorem 2. Under Assumptions 1- 4, ‖θˆ − θ˜‖ = op(1).
Theorem 2’. Under Assumptions 1, 2, 4 and 3’, θˆ − θ˜ = op(1/
√
n).
3.2 Consistency of NPMLE
Next, we show the consistency of the NPMLE.
Theorem 3. Under Assumptions 1 - 4, the NPMLE estimator for L in (1), θˆ =
(αˆ, βˆ, Λˆ(·)), is consistent. That is
αˆ−α0 → 0, βˆ − β0 → 0, sup
t∈[0,τ ]
|e−Λˆ(t) − e−Λ0(t)| → 0 a.s..
The proof follows the general framework in Murphy (1994). The estimator for the
baseline hazard satisfies the equation
Λˆ(t) =
∫ t
0
{
n∑
i=1
W θˆi (u)e
βˆ
>
Z2i
}−1
dN¯(u), (15)
where
W θi (t) =
{
δ1i + δ
c
iφ
θ
i (Xi)
}
I{t ≤ Xi} − φθi (Qi)I{t ≤ Qi}, (16)
and φθi (·) is given in (11). A bridge between Λˆ and Λ0 is constructed as
Λ¯(t) =
∫ t
0
{
n∑
i=1
φθ0i (u)Yi(u)e
β>0 Z2i
}−1
dN¯(u). (17)
The details of the proof deserve some extra comments here, as it achieves the a.s.
convergence with a baseline hazard unbounded in its support using a few innovative
steps. First, we apply Helly’s selection theorem to the Ca`dla`g function sequence e−Λˆ.
Then, the upper bound for Λˆ in any interval [0, τ∗] ⊂ (0, τ) is established via the
lower bound for n−1
∑n
i=1W
θˆ
i (u)e
βˆ
>
Z2i . We manage to show that the ratio γ(t) =
dΛˆ(t)/dΛ¯(t) is bounded between zero and infinity for all t ∈ (0, τ) despite the indefinite
quotient at 0 and τ . Finally, we conclude the proof by showing that γ(t) = 1 using an
identifiability argument.
For the purposes of the asymptotic normality below, we have a similar result:
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Theorem 3’. Under Assumptions 1, 2, 3’ and 4, the NPMLE estimator for LI defined
later in (19), θˆ = (αˆ, βˆ, Λˆ(·)), is consistent. That is
αˆ−α0 → 0, βˆ − β0 → 0, sup
t∈[0,τ ′]
|Λˆ(t)− Λ0(t)| → 0 a.s.. (18)
3.3 Asymptotic Normality of NPMLE
The divergence of the cumulative baseline hazard Λ0 at τ eventually becomes an ob-
stacle in the study of weak convergence. It is involved in all the second order terms
including both the parametric parts and the nonparametric part. Existing techniques,
mostly relying on a finite upper bound of Λ0, cannot deal with it. To proceed with the
theoretical endeavor, we avoid the divergent tail by slightly modifying the likelihood.
That is, we make an interval censoring window (τ ′, τ) close to the end of study, so
that the failure indicator A is always observed for those at-risk at time τ ′, but their
failure times are unknown if A = 1. We note that this is for technical reason only, so
that the baseline cumulative hazard is always bounded at the observed failure times
as n→∞. In practical applications this modification of the likelihood is unnecessary
since the observed SAB events are recorded in dates, so that there is always at least
one day gap between when a (possibly censored) SAB event can happen and when a
woman is considered cured.
Let δτ = A · I(X > τ ′) be the interval-censoring indicator in (τ ′, τ). Notice that
S(t)−S(τ) = S(t) for any t < τ . We have the resulting interval-censored data likelihood
that is modified from (1):
LI(θ) =
n∏
i=1
{
pλi(Xi)e
β>Z2iSi(Xi)
}δ1i (1− pi)δ0i {1− pi + piSi(Xi)}δci {piSi(τ ′)}δτi
1− pi + piSi(Qi) .
(19)
The corresponding log-likelihood lIn = logL
I is
lIn =
n∑
i=1
∫ τ ′
0
log
(
φθi (u)e
β>Z2i4Λ(u)
)
dNi(u)−
∫ τ ′
0
Yi(u)φ
θ
i (u)e
β>Z2idΛ(u)
+ {Ni(τ)−Ni(τ ′)} log φθi (τ ′) + Yi(τ) log(1− φθi (τ ′)). (20)
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The proof then follows the framework in Murphy (1995) to verify the conditions of
Theorem 3.3.1 from Van der Vaart and Wellner (1996). We shall describe the functional
space in which weak convergence is established. Let H∞ be the space containing
elements in the form of h = (a,b, η), where the vectors a and b are of the same
dimensions as α and β, respectively, and the function η(·) is defined on [0, τ ′] with
η(0) = 0 and is of bounded variation, i.e. the total variation of η over [0, τ ′],
V τ
′
0 η = sup
0=u0<···<us=τ ′
s=1,2,...
s∑
j=1
|η(uj)− η(uj−1)|
is finite. Define a norm ‖ · ‖H on H∞:
‖(a,b, η)‖H = ‖a‖1 + ‖b‖1 + V τ ′0 |η|,
and spaces indexed by a positive real number p
Hp = {h : ‖h‖H < p} .
For each p, define l∞(Hp) as the functional space of all uniformly bounded linear map
Hp 7→ R, i.e.
∀Ψ ∈ l∞(Hp), sup
h∈Hp
|Ψ(h)| <∞.
The parameter θ = (α,β,Λ) as a function in l∞(Hp) is defined as
θ(h) = a>α + b>β +
∫ τ ′
0
η(u)dΛ(u).
The induced functional norm is equivalent to the norm in (18) where consistency (The-
orem 3’) is established; we denote ‖θ‖.
Theorem 4. Let θˆ = (αˆ, βˆ, Λˆ0(·)) be the NPMLE for the log-likelihood lIn in (20).
Under Assumptions 1, 2, 3’ and 4,
√
n(θˆ − θ0) −→ G, in l∞(Hp)
weakly for a tight Gaussian process G on l∞(Hp) with covariance process
Cov(G(h),G(h∗)) = a>σ−1a (h∗) + b>σ−1b (h∗) +
∫ τ ′
0
η(u)σ−1η (h
∗)(u)dΛ0(u),
where h = (a,b, η), and σ(h) =
(
σa(h),σb(h), ση(h)
)
is given in the Appendix (A22).
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Let σˆ be a nature estimator for the operator σ by substituting the true parameter
θ0 and expectation with the estimator θˆ and the sample average.
Theorem 5. Under Assumptions 1, 2, 3’ and 4, σˆ is asymptotically equivalent to the
information matrix in (9). The solution to g = σˆ−1(h) exists with probability going to
1 as n increases and
a>σˆ−1a (h
∗) + b>σˆ−1b (h
∗) +
∫ τ ′
0
η(u)σˆ−1η (h
∗)(u)dΛˆ(u) P−→ Cov(G(h),G(h∗)).
4 Simulation study
4.1 Simulation setup
Here we detail our data simulation procedure for all of the simulation studies. Sim-
ulating cure-rate model data presents its own challenges. To be comparable with the
spontaneous abortion data which we examine in the next section, we consider finite
time τ , which is set to be 20 (weeks). The covariates are the same for the logistic
and the Cox part of the regression models and, unless otherwise specified, consisting of
Z1 ∼ N(4, 1), with corresponding parameters (α1, β1), and Z2 ∼ Bernouilli (p = 0.3),
with corresponding parameters (α2, β2). The logistic regression part also includes an
intercept α0.
We begin by generating a larger sample than we desire to account for those who
will be left out due to truncation. Values for α are chosen to procure the desired
percentage of cured individuals on average in the population, and we refer to this as
the % of cured individuals in a simulation study. An individual is designated as either
cured or not with the probability determined from the logistic model.
The baseline survival function for the Cox model is set as S0(t) = 20−t, the survival
function of a Uniform (0, 20) random variable. The baseline cumulative hazard is thus
Λ0(t) = 20{1 − e−t}. For those not cured individuals we generate an event time
T = 20{1− U exp(−β1Z1−β2Z2)}, where U ∼ Uniform (0, 1).
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Truncation times are generated from Uniform (0, a) for some a < 15 chosen so that
on average the desired percentage of uncured individuals are truncated out. We refer
to this percentage as the % of truncation. Once the truncation times are generated,
all individuals with event times less than their truncation times are removed, and we
reduce the data set to the desired sample size by taking the first n individuals from
those who remain. Finally, when there is censoring the censoring times are generated
from Uniform (15, b) for some b > 20 so that on average the desired percentage of
the n individuals (including those who are cured) will have a censoring time less than
min(Ti, 20). We refer to this percentage as the % of censoring. We ran all simulations
with 500 trials below.
4.2 Simulation results
In Tables 1 we examine the performance of the NPMLE. We consider a smaller sample
size n = 200 and a larger sample size n = 1000, and like in the pregnancy studies for
SAB we assume that a majority 75% of the subjects are cured. We ran simulations over
the combination of two truncation scenarios (10%, 20%) and two censoring scenarios
(0%, 20%). In the tables we provide the average parameter estimates (“Estimate”), the
sample standard deviation of these estimates over the 500 simulation trials (“Sample
SD”), the mean over the 500 trials of the standard errors based on our variance esti-
mation (“SE”), and the empirical coverage probabilities (“Coverage”) of the nominal
95% confidence intervals using the SE’s.
According to the table, the performance of NPMLE is quite good. The average
estimates of the parameters are generally close to their true values in all scenarios.
This includes for the Cox part of the model under the smaller sample size n = 200,
where only about 25% of the sample have events when there is no censoring, and even
few in the presence of censoring. The variance estimator generally improves with larger
sample size, especially for the Cox part of the model and with 20% censoring, which
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also reflects in the coverage probabilities of the nominal 95% confidence intervals. Note
that with 500 simulation trials these empirical coverage probabilities have about ±2%
margin of error.
5 Analysis of spontaneous abortion data
The data we investigate come from the OTIS autoimmune disease in pregnancy database
as mentioned earlier. Our sample includes pregnant women who entered a research
study between 2005 and 2012. It consists of n = 929 women who entered the study
before week 20 of their gestation, with complete covariate information. Among them
482 (52%) were pregnant women with certain autoimmune diseases who were treated
with medications under investigation, 265 (28%) were women with the same specific
autoimmune diseases who were not treated with the medications under investigation,
and the rest 182 (20%) were healthy pregnant women without autoimmune diseases
who were not treated with the medications. Chambers et al. (2001) discussed the im-
portance of having a diseased control group, since some of the adverse outcomes in
pregnancy may be due to the diseases instead of the medications. There were a total
of 66 SAB events, and 2 women were lost to follow up before 20 weeks of gestation.
There are a number of risk factors for spontaneous abortion that have been identified
in the literature (Chambers et al., 2013, for example). Alternatively, we can use a data
driven selection method for risk factors in our cure rate model. For each baseline
covariate, we use the Wald test with two degrees of freedom for both coefficients in the
logistic and the Cox part of the model. We first screen the covariates with a univariate
cure rate model, with a p-value cutoff of 0.2 for the Wald test. We then run a backward
selection, with a p-value cutoff of 0.1 for the Wald test. The selected variables are body
mass index (BMI) group (0: BMI < 18.5, 1: BMI ∈ [18.5,24.9), 2: BMI ∈ [25,29.9]),
3: BMI > 30) treated as numerical due to small number of total SAB events, gravidity
> 1 or not, i.e. whether a woman had been previously pregnant, whether there was
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smoking (Y/N) or alchohol (Y/N) intake during early pregnancy. We fit our final cure
model to the data with these covariates and exposure status, and the results using the
NPMLE are given in Table 2 left columns.
From Table 2, we see that larger body mass index significantly decreases the proba-
bility of SAB in the logistic part of the model. The probability of SAB of either healthy
control group or disease control group is not significantly different from the medication
exposed women. The Cox regression part of the model identified all four covariates
as significant factors for the hazard of SAB. In the cure model context since the Cox
model is only used for those who eventually have events (observed or censored), this
part of the model should be understood as impact of the covariates on the timing of
SAB; that is, significantly later timing of SAB for those who had larger body mass
index, gravidity > 1 or smoking, and significantly earlier timing for those who had
alcohol. Figure 2 illustrates the significance (or not) of BMI and alcohol in association
with the overall risk of SAB by 20 weeks of gestation as well as with the timing of SAB
among those women not observed to be cured.
Acounting for the left truncation, classical survival analysis methods including the
Cox proportional hazards regression model have been advocated in the literature (Meis-
ter and Schaefer, 2008; Xu and Chambers, 2011). As a comparison, Table 2 right
columns (lower half) show the results of the the classic Cox regression model fitted
to the data by treating all the cured individuals as right-censored at 20 weeks of ges-
tation, as is currently done in the practical analysis of SAB data (Chambers et al.,
2013). Gravidity and smoking are no longer significant predictors of SAB. Note that
under the proportional hazards assumption, nonsignificant effects of gravidity or smok-
ing translates to no significant differences in the cumulative risks of SAB; that is, the
impact on the timing of SAB is no longer distinguished from the impact on the overall
cumulative risk of SAB (Y/N) by 20 weeks of gestation. In addition, as mentioned
before, treating the majority of the women (who did not have SAB) as right-censored
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can lead to substantial loss of information.
Finally we also fit the ‘naive’ logistic regression model alone to the data, using
whether a woman has SAB (Y/N) as the outcome. The results are also given in the
right columns (upper half) of Table 2. We note that this model does not properly
handle left truncation, and results are wildly different from the other model fits and
should be not trusted.
6 Discussion and Conclusion
In this paper we have developed an NPMLE approach to fit the mixture type cure rate
models to data with left truncation in addition to right-censoring. As illustrated in the
data analysis, the cure rate model methodology developed here is able to make use of
the information from both the women who had SAB and those who were observed not
to have SAB, as well as to separate the differential regression effects of the covariates on
both the cumulative risk of SAB as well as the timing of it among those who experience
SAB. We anticipate this methodology to impact the practical analysis of pregnancy
and other similar types of data. An ‘alpha’ version of a corresponding R package is
currently being tested internally.
Different from the usual cure rate data where the long-term survivors are always
right-censored, in our pregnancy studies we observe the majority of the ‘cured’ women.
This greatly improves the practical identifiability of the cured portion (Sy and Taylor,
2000; Lu and Ying, 2004), as well as substantially increases the amount of information
available for estimating the model parameters. Our inference procedures utilize the
NPMLE, together with the “ghost copy” EM algorithm to produce estimators for the
model parameters. The variances of the estimators can be obtained in closed form
using the Louis (1982) formula. In our simulations, the variance estimator leads to
relatively accurate coverage of the 95% confidence intervals.
In our proof for consistency, we have worked through an unbounded cumulative
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baseline hazard, which has rarely been discussed in existing literatures. Ideally, we
would like to show asymptotic normality without assuming the interval-censoring tail
window. However, the weak convergence of nonparametric estimators often requires
a stronger set of assumptions. As a result, the unbounded Λ0 in the log-likelihood
causes trouble in the Fre´chet differentiability and continuously invertibility steps. The
“chop-off” argument applied in consistency does not work here as Λ0 appear in both
the parametric part and the nonparametric part of the directional score.
Finally for left truncated data much work has been done recently under the length-
biased assumption (Asgharian et al., 2006; Ning et al., 2010; Qin et al., 2011, among
others). For enrollment into observational pregnancy studies like ours, we do not think
that the uniform distributional assumption necessarily holds, as is evident in Figure
1. However, it would be of interest to compare the efficiency (as well as bias) of the
different approaches, and to develop methods under other parametric assumptions that
are more suitable for the entry times to pregnancy studies.
References
Andersen, P. K., Borgan, O., Gill, R. D., and Keiding, N. (1993). Statistical Models
Based on Counting Processes. Springer, New York, USA.
Asgharian, M., Wolfson, D. B., and Zhang, X. (2006). Checking stationarity of the
incidence rate using prevalent cohort survival data. Statistics in Medicine, 25(10),
1751–1767.
Chambers, C. D., Braddock, S. R., Briggs, G. G., Einarson, A., Johnson, Y. R., Miller,
R. K., Polifka, J. E., Robinson, L. K., Stepanuk, K., and Jones, K. L. (2001). Post-
marketing surveillance for human teratogenicity: a model approach. Teratology , 64,
252–261.
Chambers, C. D., Johnson, D., Xu, R., and Jones, K. L. (2011). Challenges and design
20
of a prospective, observational cohort study to assess the risk of spontaneous abortion
following administration of human papillomavirus (HPV) bivalent (types 16 and 18)
recombinant vaccine. In The 27th International Conference on Pharmacoepidemiology
and Therapeutic Risk Management , Chicago, IL, USA.
Chambers, C. D., Johnson, D., Xu, R., Luo, Y., Louik, C., Mitchell, A. A., Schatz,
M., and Jones, K. L. (2013). Risks and safety of pandemic h1n1 in uenza vaccine
in pregnancy: Birth defects, spontaneous abortion, preterm delivery, and small for
gestational age infants. Teratology , 31(44), 5026–5032.
Chen, M.-H., Ibrahim, J. G., and Sinha, D. (1999). A new bayesian model for sur-
vival data with a surviving fraction. Journal of the American Statistical Association,
94(447), 909–919.
Conway, J. B. (1990). A course in functional analysis. Springer-Verlag, New York,
second edition edition.
Farewell, V. T. (1982). The use of mixture models for the analysis of survival data
with long-time survivors. Biometrics, 38, 1041–1046.
Farewell, V. T. (1986). Mixture models in survival analysis: Are they worth the risk?
Canadian Journal of Statistics, 14(3), 257–262.
Gamst, A., M, D., and Xu, R. (2009). Asymptotic properties and empirical evaluation
of the npmle in the proportional hazards mixed-effects model. Statistica Sinica, 19,
997–1011.
Hanson, T., Bedrick, E. J., Johnson, W. O., and Thurmond, M. C. (2003). A mixture
model for bovine abortion and foetal survival. Statistics in Medicine, 22(10), 1725–
1739.
Johansen, S. (1983). An extension of Cox’s regression model. International Statistics
Review , 51, 165–174.
21
Kim, Y.-J. and Jhun, M. (2008). Cure rate model with interval censored data. Statistics
in Medicine, 27(1), 3–14.
Kuk, A. Y. and Chen, C.-H. (1992). A mixture model combining logistic regression
with proportional hazards regression. Biometrika, 79(3), 531–541.
Li, C.-S., Taylor, J. M., and Sy, J. P. (2001). Identifiability of cure models. Statistics
& Probability Letters, 54(4), 389–395.
Louis, T. (1982). Finding the observed information matrix when using the em algo-
rithm. Journal of the Royal Statistical Society, Series B , 44(2), 226–233.
Lu, W. and Ying, Z. (2004). On semiparametric transformation cure models.
Biometrika, 91(2), 331–343.
Meister, R. and Schaefer, C. (2008). Statistical methods for estimating the probability
of spontaneous abortion in observational studies - analyzing pregnancies exposed to
coumarin derivatives. Reproductive Toxicology , 26, 31–35.
Murphy, S. A. (1994). Consistency in a proportional hazards model incorporating a
random effect. Annals of Statistics, 22(2), 712–731.
Murphy, S. A. (1995). Asymptotic theory for the frailty model. Annals of Statistics,
23(1), 182–198.
Ning, J., Qin, J., and Shen, Y. (2010). Non-parametric tests for right-censored data
with biased sampling. Journal of the Royal Statistical Society, Series B , 72, 609–630.
Qin, J., Ning, J., Liu, H., and Shen, Y. (2011). Maximum likelihood estimations and
EM algorithms with length-biased data. Journal of the American Statistical Associa-
tion, 106(496), 1434–1449.
Sy, J. P. and Taylor, J. M. (2000). Estimation in a cox proportional hazards cure
model. Biometrika, 56(1), 227–236.
22
Vaida, F. and Xu, R. (2000). Proportional hazards model with random effects. Statistics
in Medicine, 19, 3309–3324.
Van der Vaart, A. W. and Wellner, J. A. (1996). Weak convergence and empirical
processes. Springer Series in Statistics. Springer-Verlag, New York.
Vardi, Y. (1985). Empirical distributions in selection bias models. Annals of Statistics,
13(1), 178–203.
Wilcox, A. J., Weinberg, C. R., O’Connor, J. F., Baird, D. D., Schlatterer, J. P.,
Canfield, R. E., Armstrong, E. G., and Nisula, B. C. (1988). Incidence of early loss of
pregnancy. New England Journal of Medicine, 319(4), 189–194.
Xu, R. and Chambers, C. (2011). A sample size calculation for spontaneous abortion
in observational studies. Reproductive Toxicology , 32(4), 490–493.
Zeng, D. and Lin, D. Y. (2007). Maximum likelihood estimation in semiparametric
regression models with censored data. Journal of the Royal Statistical Society, Series
B , 69, 507–564.
Zeng, D., Yin, G., and Ibrahim, J. G. (2006). Semiparametric transformation models
for survival data with a cure fraction. Journal of the American Statistical Association,
101, 670–684.
23
A Appendix A: Proofs
A.1 The Existence of NPMLE
Proof of Theorem 1. Let θB be the maximizer on the compliment of compact set {‖α‖∨
‖β‖ ∨ ‖λ‖ ≤ B}. We show that l(θB)→ −∞ when B →∞.
By Assumptions 1 and 2, we have the bound (12).
All terms in the log-likelihood are bounded except for
n∑
i=1
{
δ1i log λ(Xi)− δ1i eβ
>Z2iΛ(Xi)
}
.
Let λmax be the largest element in λ. The expression above has the upper bound
log(λmax/m)− λmax/m−K logm,
which diverges to −∞ when we set B →∞.
Then, the global maximizer must be in one of the compact set {‖α‖∨ ‖β‖∨ ‖λ‖ ≤
B∗} for some B∗ > 0.
Let W θi (t) be defined as in (16). We define a generic inequality to be referenced
later, for any θ = (α,β,Λ) in the parameter space whose baseline cumulative hazard
Λ is a step function jumping only at the observed event times, t1, . . . , tK :
0 < dΛ(tk) ≤
 n∑
j=1
W θj (tk)e
β>Z2j
−1 dN¯(tk), k = 1, . . . ,K. (A1)
The conclusion of the following Lemma is used in the proofs of both Lemma 1 and
Theorem 3.
Lemma A1. Let θ(n) =
(
α(n),β(n),Λ(n)
)
be a sequence in the parameter space where
Λ(n) is a non-decreasing step function with jumps only at the observed event times.
Suppose that θ(n) satisfies (A1) and has a subsequence θ(nk) converging to a limiting
point θ∗ = (α∗,β∗,Λ∗) a.s.:
α(nk) −α∗ → 0, β(nk) − β∗ → 0, sup
t∈[0,τ ]
|e−Λ(nk)(t) − e−Λ∗(t)| → 0, a.s.. (A2)
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Under Assumptions 1 - 4,
a) Λ∗(t) <∞ for all t < τ ;
b) inft∈[0,ζ]E[W θ
∗
(t)eβ
∗>Z2 ] > Cw, for some Cw > 0.
Proof of Lemma A1. By checking the uniform continuity ofW θi (t)e
β>Z2i in (α,β, e−Λ(t)),
we may establish
sup
t∈[0,τ ]
∣∣∣W θ∗i (t)eβ∗>Z2i −W θ(nk)i (t)eβ>(nk)Z2i∣∣∣→ 0, a.s..
W θi (t) as a function of observed random variables belongs to a Glivenko-Cantelli class
of uniformly bounded functions with uniformly bounded variation. Thus, the pointwise
convergence can be strengthen to be uniform convergence,
sup
t∈[0,τ ]
∣∣∣∣∣ 1n
nk∑
i=1
W
θ(nk)
i (t)e
β>(nk)Z2i − E
[
W θ
∗
(t)eβ
∗>Z2
]∣∣∣∣∣ a.s.−→ 0.
Note that n−1
∑nk
i=1W
θ(nk)
i (t)e
β>(nk)Z2i is ca`gla`d, so its limit E[W θ
∗
(t)eβ
∗>Z2 ] must
also be ca`gla`d.
a) Let τ∗ = inf{t ∈ [0, ζ] : e−Λ∗(t) = 0}. We shall prove that τ∗ = τ .
Suppose that τ∗ is an interior point of [0, τ ]. From Assumption 4, dΛ0([s, t]) = Λ0(t)−
Λ0(s) > 0 for any s < t in [0, τ ]. By the definition of τ
∗, Λ∗(t) =∞ and φθ∗(t) = 0 for
t ∈ [τ∗, τ ], so we have
E
[
W θ
∗
(τ∗)eβ
∗>Z2
]
= E
[∫ τ
τ∗−
eβ
∗>Z2dN(u)
]
> 0.
By the left continuity of W θi (t), ∃ s < τ∗, s.t.
inf
t∈[s,τ∗]
E
[
W θ
∗
(t)eβ
∗>Z2
]
≥ 1
2
E
[∫ τ
τ∗−
eβ
∗>Z2dN(u)
]
.
The total increment of Λ(nk) in [s, τ
∗] must be bounded almost surely according to (A1).
By the definition of τ∗, Λ∗(s) <∞. Putting these together, we reach the contradiction,
Λ∗(τ∗) ≤ lim
k→∞
Λ(nk)(τ
∗) ≤ lim
k→∞
Λ(nk)(s) +
∫ τ∗
s+
dN¯(u)∑nk
i=1W
θ(nk)
i (u)e
β>(nk)Z2i
≤Λ∗(s) + τ
∗ − s
inft∈[s,τ∗]E[W θ
∗
(t)eβ
∗>Z2 ]
<∞.
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The other case is τ∗ = 0. Then, Λ∗(t) = ∞ and φθ∗(t) = 0 for t ∈ [0, τ ]. The
contradiction is easily established as
E
[
W θ
∗
(0)eβ
∗>Z2
]
= E
[∫ τ
0
eβ
∗>Z2dN(u)
]
> 0.
b) Since E[W θ
∗
(t)eβ
∗>Z2 ] is ca`gla`d, θ(nk) satisfies (A1) and converges uniformly to
θ∗, it can be seen that E[W θ
∗
(t)eβ
∗>Z2 ] ≥ 0 over the interior of [0, ζ].
Write n−1k
∑nk
i=1W
θ
i (t)e
β>Z2i as
n−1k
nk∑
i=1
∫ τ
t−
{
1− φθi (u)
}
eβ
>Z2idNi(u) +
∫ τ
t
Yi(u)e
β>Z2idφθi (u) + Yi(t)φ
θ
i (t)e
β>Z2i
=n−1k
nk∑
i=1
∫ τ
t+
[
1− φθi (u)−
∑nk
j=1 Yj(u)φ
θ
j (u)
{
1− φθj (u)
}
eβ
>Z2j∑nk
j=1W
θ
j (u)e
β>Z2j
]
eβ
>Z2idNi(u)
+
{
1− φθi (t)
}
eβ
>Z2idNi(t) + Yi(t)φ
θ
i (t)e
β>Z2i . (A3)
By Assumption 4, all Qi < ζ a.s.. Thus,
E
[
W θ
∗
(ζ)eβ
∗>Z2
]
=E
[{
δ1 + δcφθ
∗
(X)
}
I{ζ ≤ X}eβ∗>Z2
]
≥E
[∫ τ
ζ
eβ
∗>Z2dN(u)
]
> 0.
For t < ζ, the difference E[W θ
∗
(t)eβ
∗>Z2 ]−E[W θ∗(ζ)eβ∗>Z2 ] is the limit of an integral
like that in (A3), where the integrand has
∑nk
j=1W
θ
j (u)e
β>Z2j in the denominator.
So it has potential singularities at the zeros of E[W θ
∗
(u)eβ
∗>Z2 ] for u ∈ [t, ζ]. We
shall show that E[W θ
∗
(u)eβ
∗>Z2 ] is differentiable with respect to dΛ0(u) in [0, ζ], so
that its zero u0 leads to the divergent form −
∫ ζ
t |u− u0|−1du. We will then reach the
contradiction that E[W θ
∗
(t)eβ
∗>Z2 ] = −∞, as seen below.
Denote R0 the set of zeros and limiting zeros from right for E[W
θ∗(u)eβ
∗>Z2 ]. Let
set R4u be the 4u neighborhood of R0 and Ωt4u = [t, ζ] \ R4u. E[W θ
∗
(u)eβ
∗>Z2 ] is
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bounded away from zero on Ωt4u. Through (A3),
E
[
W θ
∗
(t)eβ
∗>Z2
]
− E
[
W θ
∗
(ζ)eβ
∗>Z2
]
≤ −
∫
Ωt4u
E[Y (u)φθ
∗
(u)
{
1− φθ∗(u)}eβ∗>Z2 ]
E[W θ
∗
(u)eβ
∗>Z2 ]
E
[
eβ
∗>Z2dN(u)
]
+ E
[∫ ζ
t+
{1− φθ∗(u)}dN(u) + {1− φθ∗(t)}eβ∗>Z2dN(t) + Y (t)φθ∗(t)eβ∗>Z2] .
(A4)
From part a), e−Λ∗(ζ) > 0. For any u < ζ,
φθ
∗
i (u) ≥ φθ
∗
i (ζ) ≥
m−1e−mΛ∗(ζ)
1 +m−1e−mΛ∗(ζ)
> 0.
So the limit of numerator term E[Y (u)φθ
∗
(u){1 − φθ∗(u)}eβ∗>Z2 ] is bounded away
from zero. And ∀u ∈ [0, ζ],∣∣∣∣dEW θ∗(u)dΛ0(u)
∣∣∣∣ = ∣∣∣∣E [{1− φθ∗(u)}Y (u)φθ0(u)eβ>0 Z2 − φθ∗(u)dE[Y (u)|Z1,Z2]dΛ0(u)
]∣∣∣∣
≤m+ L <∞.
The first term in (A4) diverges to −∞ when 4u → 0. The other terms are bounded,
so this is the desired contradiction.
Proof of Lemma 1. For any θ denote λmax,ζ = max{λk : tk ≤ ζ}, where ζ is the upper
bound of truncation time defined in Assumption 4. Define a set in the parameter space:
Θ =
{
θ = (α,β,Λ)|λmax,ζ ≤ n−12/Cw
}
, (A5)
with Cw defined in Lemma A1. We would like to show that
lim
n→∞P (θˆ, θ˜ ∈ Θ̂) = 1. (A6)
This is done through applying Lemma A1, so we will need to verify condition (A1) for
θ˜ and θˆ.
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First, define the marginal of the complete data likelihood
L˜(θ) =
∑
Ai=0,1
∞∑
Mi=0
∑
T˜i1=tk:tk≤Qi
· · ·
∑
T˜iMi=tk:tk≤Qi
Lci (θ)
=
n∏
i=1
{
piλi(Xi)Si(Xi)
}δ1i (1− pi)δ0i {piSi(Xi) + 1− pi}δci
1− pi
∑
k:tk≤Qi λke
β>Z2iSi(tk)
.
From (2) it can be seen that the complete data likelihood Lc(θ) can be decomposed
into the product of one logistic part concave in α with one Cox part concave in (β,λ).
Thus, it is concave in θ. L˜(θ) is also concave as the sum over concave functions.
Next we show that the EM finds the unique stationary point of L˜(θ), which then
must be the global maximizer since it is concave. Consider the conditional expectation
given the observed data as in (5) - (7). It can be verified directly (we skip the algebraic
details here) that:
∇ log L˜(θ) = Eθ[∇ logLc(θ)|O].
The estimator θ˜ is by definition the solution to the left-hand side of the above being
zero, hence also the stationary point of L˜(θ).
We write down the stationary equation θ(l) = θ(l+1) = θ˜ for λ˜k’s at convergence,
λ˜k =
1 + λ˜k
∑n
i=1
p˜ie
β˜>Z2i S˜i(tk)I(Qi≥tk)
1−p˜i
∑
h:h<Qi
f˜i(th)∑n
i=1
{
δ1i I(Xi ≥ tk) + δciφθ˜i (Xi)I(Xi ≥ tk) +
∑
j≥k
p˜if˜i(tj)I(Qi≥tj)
1−p˜i
∑
h:h<Qi
f˜i(th)
}
eβ˜>Z2i
,
where fi was previously defined just above (3). Combining λ˜k terms leads to
λ˜−1k =
n∑
i=1
{
δ1i I(Xi ≥ tk) + δciφθ˜i (Xi)I(Xi ≥ tk)
− p˜i
S˜i(tk)I(Qi ≥ tk)−
∑
j≥k f˜i(tj)I(Qi ≥ tj)
1− p˜i
∑
h:h<Qi
f˜i(th)
}
eβ˜>Z2i . (A7)
By the mean value theorem,
0 ≤ eλkeβ
>Z2i − 1− λkeβ>Z2i ≤ 1
2
(
λke
β>Z2i
)2
eλke
β>Z2i ≤ 1
2
m2λ2ke
λkm. (A8)
where m is defined in (12). Applying (A8) to the denominator in (A7), we get
1− p˜i
∑
h:h<Qi
f˜i(th) ≥ 1− p˜i{1− S˜i(Qi)}.
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By a similar argument, we have almost surely
S˜i(tk)I(Qi ≥ tk)−
∑
j≥k
f˜i(tj)I(Qi ≥ tj)
= S˜i(Qi)I(Qi ≥ tk) +
∑
j≥k
{
1− e−λ˜jeβ˜>Z2i − λ˜jeβ˜>Z2i
}
S˜i(tj)I(Qi > tj)
≤ S˜i(Qi)I(Qi ≥ tk).
Then, θ˜ satisfies (A1).
For θˆ, it must satisfy the score equation for λk’s:
∂l(θ)
∂λk
=
n∑
i=1
{
dNi(tk)
λk
−W θi (tk)eβ
>Z2i
}
= 0, ∀k = 1, . . . ,K.
This is the equation version of (A1) after rearrangement.
Now let λˆmax,ζ and λ˜max,ζ be the largest jump for Λˆ and Λ˜ on [0, ζ], correspondingly.
By Lemma A1 part b), we have
lim sup
n→∞
nλˆmax,ζ ≤ C−1w , lim sup
n→∞
nλ˜max,ζ ≤ C−1w , a.s..
Hence (A6) is established.
In the set Θ, we evaluate the discrepancy between log L˜(θ) and logL(θ), which can
be bounded as following
1−Si(Qi)−
∑
k:tk<Qi
λke
β>Z2iSi(tk) =
∑
k:tk<Qi
Si(tk)
(
eλke
β>Z2i − 1− λkeβ>Z2i
)
. (A9)
Applying (A8) to | logL(θ)− log L˜(θ)|, we have the bound
∣∣∣logL(θ)− log L˜(θ)∣∣∣ ≤ n∑
i=1
∣∣∣∣∣∣log {1− pi + piSi(Qi)} − log
1− pi ∑
k:tk<Qi
λke
β>Z2iSi(tk)

∣∣∣∣∣∣
≤
n∑
i=1
∣∣∣∣ pi1− pi n2m2λ2keλkm
∣∣∣∣ ≤ 12n2emλmax,ζm3λ2max,ζ .
Using the upper bound for λmax,ζ in Θ, we can bound
sup
θ∈Θ
∣∣∣logL(θ)− log L˜(θ)∣∣∣ ≤ e 2mCw 2m3
C2w
. (A10)
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In summary whenever θˆ, θ˜ ∈ Θ, we have
0 ≤ logL(θˆ)− logL(θ˜) ≤ logL(θˆ)− log L˜(θˆ) + log L˜(θ˜)− logL(θ˜) < e 2mCw 4m
3
C2w
. (A11)
Combining (A11) and (A6) completes the proof.
Proof of Theorem 2 and 2’. From Lemma 1, we only need to establish the following
two facts: 1) E[l1(θ)] exists with one unique maximal, and 2) it is locally invertible at
the maximal. We will see that 1) is verified through the proof of Theorem 3, and 2) is
verified through the proof of Theorem 4.
A.2 Consistency of NPMLE
Proof of Theorem 3. The constants m, c, ε and L are defined in (12), (13) and (14).
First, we show that the “bridge” Λ¯ defined in (17) converges to the true Λ0 in the
following sense:
sup
t∈[0,τ ]
∣∣∣e−Λ¯(t) − e−Λ0(t)∣∣∣→ 0, a.s. (A12)
as n→∞. We have the bound for ∀t ∈ (0, τ),
m ≥
E
[
Y (t)φθ0(t)eβ
>
0 Z2
]
E
[
log
{
1 + exp
(
α>0 Z1 − Λ0(t)eβ
>
0 Z2i
)}] ≥ ε
m2 +m
. (A13)
For any τ∗ < τ in Q the set of rational numbers, E[Y (t)φθ0(t)eβ>0 Z2 ] is bounded away
from zero over [0, τ∗]. The uniform convergence of Λ¯ to Λ0 over any [0, τ∗] can be
obtained in the way like Murphy (1994). To extend the result to (A12), we use a trick
described in (A14)-(A17). By Assumption 3, Λ0 is non-decreasing and diverges to ∞
at τ . Therefore,
∀ > 0, ∃τ∗ ∈ (0, τ) ∩Q, s.t. e−Λ0(τ∗) < /3. (A14)
Through Rao’s law of large number and Helly-Bray argument, we have
sup
t∈[0,τ∗]
|Λ¯(t)− Λ0(t)| → 0, a.s.. (A15)
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By continuity of the exponential function,
∃N, ∀n > N, sup
t∈[0,τ∗]
|e−Λ¯(t) − e−Λ0(t)| < /3. (A16)
Then,
∀n > N, sup
t∈[τ∗,τ ]
|e−Λ¯(t) − e−Λ0(t)| ≤ 2e−Λ0(τ∗) + |e−Λ¯(τ∗) − e−Λ0(τ∗)| < . (A17)
Therefore, we have proved (A12).
Next, we evaluate the difference between the limits of Λˆ and Λ¯. According to
Assumption 1 and e−Λˆ(t) ∈ [0, 1], (αˆ, βˆ, e−Λˆ(t)) is bounded. Λˆ(t) is Ca`dla`g, so is e−Λˆ(t).
By Helly’s Selection theorem, there is a subsequence converging uniformly almost surely
to some θ∗ = (α∗,β∗, e−Λ∗). Lemma A1 part b) gives the bound for E{W θ(t)eβ>Z2}
over [0, ζ]. We only need to find its bound on [ζ, τ ] in order to mimic the proof of
Lemma 1 of Murphy (1994). Note that
E
[
W θ(t)eβ
>Z2
]
=E
[∫ τ
t−
{
1− φθ(u)}eβ>Z2dN(u)]
− E
[∫ τ
t
φθ(u)eβ
>Z2dE[Y (u)|Z1,Z2]
]
.
By Assumption 4, P (Qi ≤ ζ) = 1, so E[Y (u)|Z1,Z2] is decreasing on [ζ, τ ]. Along
with the Lipschitz continuity, we have for ∀t ∈ [ζ, τ)
ML ≥ E[W
θ(t)eβ
>Z2 ]
E
[
log
{
1 + exp
(
α>0 Z1 − Λ0(t)eβ
>
0 Z2i
)}] ≥ ε
m2 +m
.
Therefore, γ(t) =
E
[
Wθ0 (t)eβ
>Z2
]
E
[
Wθ∗ (t)eβ∗>Z2
] is bounded away from both ∞ and zero, and
sup
t∈[0,τ ]
∣∣∣∣∣dΛˆdΛ¯(t)− γ(t)
∣∣∣∣∣→ 0 and supt∈[0,τ∗]
∣∣∣∣Λˆ(t)− ∫ t
0
γdΛ0
∣∣∣∣→ 0 a.s.,∀τ∗ < τ in Q. (A18)
After all these preparation, we can use the semi-parametric Kullback-Leibler diver-
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gence argument from Murphy (1994). We have
0 ≤ 1
n
{
ln(αˆ, βˆ, Λˆ)− ln(α0,β0, Λ¯)
}
=
1
n
n∑
i=1
∫ τ
0
log
{
φθˆi (u)e
βˆ
>
Z2idΛˆ(u)
φθ0i (u)e
β>0 Z2idΛ¯(u)
}{
dNi(u)− φθ0i (u)Yi(u)eβ
>
0 Z2idΛ¯(u)
}
+
∫ τ
0
[
log
{
φθˆi (u)e
βˆ
>
Z2idΛˆ(u)
φθ0i (u)e
β>0 Z2idΛ¯(u)
}
−
{
φθˆi (u)e
βˆ
>
Z2idΛˆ(u)
φθ0i (u)e
β>0 Z2idΛ¯(u)
− 1
}]
× φθ0i (u)eβ
>
0 Z2iYi(u)dΛ¯(u). (A19)
Denote the function in the logarithm above as ψi(u). Using the definition of Λ¯, we can
rewrite the first term in (A19) as
1
n
n∑
i=1
{∫ τ
0
log
(
ψi(u)
)− ∑nj=1 log (ψj(u))φθ0j (u)Yj(u)eβ>0 Z2j∑n
j=1 φ
θ0
j (u)Yj(u)e
β>0 Z2j
}
dNi(u)
=
1
n
n∑
i=1
{∫ τ
0
log
(
ψi(u)
)− ∑nj=1 log (ψj(u))φθ0j (u)Yj(u)eβ>0 Z2j∑n
j=1 φ
θ0
j (u)Yj(u)e
β>0 Z2j
}
dMi(u) (A20)
Inside ψi(u), the ratio dΛˆ/dΛ¯ is bounded away from 0 and ∞ according to (A18).
Denote the range of the ratio as [1/R,R]. The φθ0i (u) term and φ
θˆ
i (u) term in ψi(u)
creates potential singularity for (A20) at τ , but its decay rate is bounded by e−mRΛ0(u)
by Assumptions 1 and 2. The integrands of martingale integral (A20) are all bounded
a.s., and the quadratic variation of (A20) is bounded a.s. by
1
n2
n∑
i=1
∫ τ
0
4
{
mRΛ0(u) + log(R)
}2
φθ0i (u)Yi(u)e
β>0 Z2idΛ0(u).
It is of order Op(1/n), so the limit of (A20) is zero almost surely.
The integrands in the second term of (A19) is of the form log(x)− (x− 1) ≤ 0. In
order to satisfy the inequality in (A19), we must have
lim
n→∞
1
n
n∑
i=1
∫ τ
0
{
log
(
ψi(u)
)− (ψi(u)− 1)}φθ0i (u)eβˆ>Z2iYi(u)dΛ¯(u) = 0.
Applying the same argument as in Murphy (1994), we get
E
(∫ τ
0
∣∣∣φθ∗(u)eβ∗>Z2γ(u)− φθ0(u)eβ>0 Z2∣∣∣Y (u)dΛ0(u)) = 0 (A21)
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in the almost sure set. The identifiability of our model is verified in Li et al. (2001)
Theorem 2. Along with our regularity conditions in Assumptions 2 and 3, (A21) leads
to α∗ = α0, β∗ = β0 and γ(t) = 1. This implies that
sup
t∈[0,τ∗]
∣∣∣Λˆ(t)− Λ0(t)∣∣∣→ 0 a.s.,∀τ∗ < τ in Q.
Repeating the trick in (A14)-(A17), we have
sup
t∈[0,τ ]
∣∣∣e−Λˆ(t) − e−Λ0(t)∣∣∣→ 0 a.s..
Finally, we summarize all usage of almost sure arguments to ensure that intersection
of all almost sure sets still has probability one under σ-additivity. The steps (A14)-
(A17) involves one almost sure argument for each choice of τ∗. We preserve the almost
sure property by restricting τ∗ to be in the countable set Q. One almost sure argument
is made for Helly’s selection theorem. In Lemma A1, we use the Glivenko-Cantelli
Theorem to avoid the dependence on the choice of θ∗, so the almost sure argument is
only applied once. Two more almost sure arguments are used in calculating the limit
of the terms in (A19).
Proof of Theorem 3’. The proof is essentially the same as the proof of Theorem 3, so
the details are omitted. In fact, it is less technical due to the boundedness of Λ0 over
[0, τ ′].
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A.3 Asymptotic Normality
First, we provide the definition of several quantities below. In Theorem 4 σ(h) =(
σa(h),σb(h), ση(h)
)
is
σa(h) = E
[
Z1
{
−
∫ τ ′
0
Kθ01 (h)(u)Y (u)dφ
θ0(u)
+Kθ02 (h)Y (τ
′)φθ0(τ ′)
(
1− φθ0(τ ′)
)}]
,
σb(h) = E
[
Z2
{∫ τ ′
0
Kθ01 (h)(u)Y (u)e
β>0 Z2d
[
Λ0(u)φ
θ0(u)
]
−Kθ02 (h)Y (τ ′)eβ
>
0 Z2Λ0(τ
′)φθ0(τ ′)
(
1− φθ0(τ ′)
)}]
,
ση(h) = E
[
eβ
>
0 Z2
{
Kθ01 (h)(u)φ
θ0(u)Y (u)−Kθ02 (h)Y (τ ′)φθ0(τ ′)
(
1− φθ0(τ ′)
)
−
∫ τ ′
u
Kθ01 (h)(s)φ
θ0(s)
(
1− φθ0(s)
)
Y (s)eβ
>
0 Z2dΛ0(s)
}]
, (A22)
where
Kθ1 (h)(u) =a
>Z1
(
1− φθ(u)
)
+ b>Z2
{
1−
(
1− φθ(u)
)
Λ(u)eβ
>Z2
}
+ η(u)−
(
1− φθ(u)
)
eβ
>Z2
∫ u
0
ηdΛ,
Kθ2 (h) =
{
a>Z1 − b>Z2Λ(τ ′)eβ>Z2 −
∫ τ ′
0
ηeβ
>Z2dΛ
}
. (A23)
Let θ + th =
(
α + ta,β + tb,
∫ ·
0(1 + tη)dΛ
)
. Define the directional derivatives
lim
t→0
lIn(θ + th)− lIn(θ)
t
= Sθn = S
θ
n,a + S
θ
n,b + S
θ
n,η,
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where
Sθn,a =
1
n
n∑
i=1
a>Z1i
{∫ τ ′
0
(
1− φθi (u)
)
dNi(u)−
∫ τ ′
0
Yi(u)φ
θ
i (u)
(
1− φθi (u)
)
eβ
>Z2idΛ(u)
+
(
Ni(τ)−Ni(τ ′)
)(
1− φθi (τ ′)
)
− Yi(τ)φθi (τ ′)
}
Sθn,b =
1
n
n∑
i=1
b>Z2i
[ ∫ τ ′
0
{
1−
(
1− φθi (u)
)
Λ(u)eβ
>Z2i
}
dNi(u)
+
∫ τ ′
0
Yi(u)φ
θ
i (u)e
β>Z2i
{(
1− φθi (u)
)
Λ(u)eβ
>Z2i − 1
}
dΛ(u)
−
(
Ni(τ)−Ni(τ ′)
)(
1− φθi (τ ′)
)
Λ(τ ′)eβ
>Z2i + Yi(τ)φ
θ
i (τ
′)Λ(τ ′)eβ
>Z2i
]
Sθn,η =
1
n
n∑
i=1
∫ τ ′
0
[
η(u)−
{
1− φθi (u)
}
eβ
>Z2i
∫ u
0
ηdΛ
]
dNi(u)
+
∫ τ ′
0
Yi(u)φ
θ
i (u)e
β>Z2i
[{
1− φθi (u)
}
eβ
>Z2i
∫ u
0
ηdΛ− η(u)
]
dΛ(u)
−
(
Ni(τ)−Ni(τ ′)
)(
1− φθi (τ ′)
)∫ τ ′
0
ηdΛeβ
>Z2i + Yi(τ)φ
θ
i (τ
′)
∫ τ ′
0
ηdΛeβ
>Z2i .
Their expectations are denoted as
Sθ = Sθa + S
θ
b + S
θ
η = E
(
Sθn,a
)
+ E
(
Sθn,b
)
+ E
(
Sθn,η
)
.
Again let θ0 be the true parameter and θ another element in the paramter space.
Define 4θ = θ − θ0 with
4α = α−α0, 4β = β − β0 and 4Λ(·) =
{
Λ(·)− Λ0(·)
}
.
Define linΘ to be the linear space spanned by {θ − θ0 : θ in parameter space}. Let
θt = θ0 + t4θ. The functional Hessian is a linear operator linΘ 7→ l∞(Hp) defined as
S˙θ0(4θ)(h) = lim
t→0
Sθt(h)− Sθ0(h)
t
=−4α>σa(h)−4β>σb(h)−
∫ τ ′
0
ση(h)(u)d4Λ(u) (A24)
with σ defined in (A22).
The following Lemma A2 is used in the proofs of Theorems 4 and 5. It tells us
about the property of σ, the essential element in the functional Hessian.
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Lemma A2. Let the operator σ : (a,b, η) 7→
(
σa(h),σb(h), ση(h)
)
be defined as in
(A22). Under the conditions of Theorem 4, σ is a continuously invertible bijection from
H∞ to H∞.
Proof of Lemma A2. First we prove that σ is injection by an identifiability argument.
Define an inner-product between σ(h) and h as
〈
σ(h),h
〉
=a>σa(h) + b>σb(h) +
∫ τ ′
0
ση(h)(u)η(u)dΛ0(u)
=
∫ τ ′
0
E
[{
Kθ01 (h)(u)
}2
Y (u)φθ0(u)eβ
>
0 Z2
]
dΛ0(u)
+ E
[{
Kθ02 (h)
}2
Y (τ ′)φθ0(τ ′)
(
1− φθ0(τ ′)
)]
.
If
〈
σ(h),h
〉
= 0, we have almost surely Kθ02 (h) = 0 and K
θ0
1 (h)(u) = 0 a.e. u ∈ [0, τ ′].
Therefore, ∫ t
0
Kθ01 (h)(u)φ
θ0(u)eβ
>
0 Z2dΛ0(u) = 0,∀t ∈ [0, τ ′], a.s..
Calculating the integral, we have for for any t ∈ [0, τ ′] a.s.
−a>Z1φθ0(t) + b>Z2φθ0(t)Λ0(t)eβ>0 Z2 +
∫ t
0
η(u)dΛ0(u)φ
θ0(t)eβ
>
0 Z2 = 0.
Setting t = 0, we have −a>Z1φθ0(0) = 0, so a>Z1 = 0. By Assumption 2, a = 0.
Plugging a = 0 into Kθ02 yields
Kθ02 (h) = e
β>0 Z2
{
b>Z2Λ0(τ ′)−
∫ τ ′
0
η(u)dΛ0(u)
}
= 0, a.s..
Again, b>Z2 =
∫ τ ′
0 η(u)dΛ0(u)/Λ0(τ
′) is deterministic, so b = 0. This way η must also
be constantly zero. As a result, σ(h) = σ(h′)⇒
(
σ(h− h′),h− h′
)
= 0⇒ h = h′.
To show it is a bijection, we apply Theorem 3.11 in Conway (1990). It suffices to
decompose σ as the sum of one invertible operator and one compact operator. The
invertible operator is defined as
Σ(h) =
(
E
(
Z1Z1
>
)
a, E
(
Z2Z2
>
)
b, η(t)E
{
eβ
>
0 Z2φθ0(t)Y (t)
})
.
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Since E
(
Z1Z1
>), E (Z2Z2>) are both positive definite, and inft∈[0,τ ′]Eeβ>0 Z2φθ0(t)Y (t) >
0, the inverse exists as
Σ−1(h) =
( [
E
{
Z1Z1
>}]−1 a, [E{Z2Z2>}]−1 b, η(t) [E{eβ>0 Z2φθ0(t)Y (t)}]−1 ).
For the compactness of σ(h) − Σ(h), classical Helly-selection plus dominated conver-
gence method applies as all terms are conveniently bounded.
The proof of Theorem 4 is the application of Theorem 3.3.1 from Van der Vaart
and Wellner (1996). We shall verify all the required conditions for the Theorem.
Proof of Theorem 4. Since we work under a modified Assumption 3’ now, the mar-
tingale representation in (10) needs to change accordingly beyond τ ′. We still use
Mi(t) as the notation. Define the filtrations
{Ft : t ∈ [0, τ ]}. On [0, τ ′], Ft is
the natural σ-algebra generated by {Ni(t), Yi(t),Z1i,Z2i, i = 1, . . . , n}. Since there
is no extra information in the tail window (τ ′, τ), we set Ft = Fτ ′ for t ∈ (τ ′, τ).
Fτ is the σ-algebra generated by {Ni(τ) − Ni(τ ′), Yi(τ),Z1i,Z2i, i = 1, . . . , n}, where
Yi(τ) = Yi(τ
′)− dNi(τ ′) is measurable in Fτ ′ . The filtrations on [0, τ ′] stay the same,
so Mi(t) defined in (10) is still a martingale up to time τ
′. In the tail window (τ ′, τ),
we set Mi(t) constantly equals Mi(τ
′). To extend its definition to time τ , we define
dMi(τ) = Mi(τ)−Mi(τ ′) =
{
Ni(τ)−Ni(τ ′)
}− Yi(τ)φθ0i (τ ′). (A25)
It is easy to verify that E[Mi(τ)|Fτ ′ ] = Mi(τ ′), so Mi(t) thus defined is a martingale
with respect to the new filtrations
{Ft : t ∈ [0, τ ′] ∪ {τ}}. Analogously, we define the
process Mθi (·) which replaces the true parameter θ0 in Mi(·) by arbitrary θ in the
parameter space. Apparently, Mθ0i (·) = Mi(·). From here, we establish the needed
results based on the martingale theory.
First, we prove weak convergence of the empirical score
√
n(Sθ0n − Sθ0)
l∞(Hp)−→ W. (A26)
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Notice that Sθ01 −Sθ0 is a martingale integral with respect to (A25). The weak conver-
gence follows from martingale central limit theorem. The covariance process is given
by the expectation of its quadratic variation:
Cov
(
G (h),G (h∗)
)
= E
[ ∫ τ ′
0
Kθ01 (h)K
θ0
1 (h
∗)Y (u)φ0(u)eβ
>
0 Z2dΛ0(u)
+Kθ02 (h)K
θ0
2 (h
∗)φ0(τ ′)
{
1− φ0(τ ′)
}]
,
where K1 and K2 are defined as in (A23).
Next, we verify the approximation condition
√
n
(
Sθˆn − Sθˆ − Sθ0n − Sθ0
)
= op(1). (A27)
Consider the class {Sθ1 (h)−Sθ01 (h) : ‖θ− θ0‖ ≤ ε,h ∈ Hp}. All terms involved in this
class are uniformly bounded with uniformly bounded variation, so it is a Donsker class
for the set of observable random variables. By checking that φθi is Lipschitz in θ under
the l∞(Hp) norm, we have almost surely
sup
t,Z2,Z1
|φθi (t)− φθ0i (t)| = O (‖θ − θ0‖) ,
and similarly
sup
t,Z2,Z1
|φθi (t)Λ(t)− φθ0i (t)Λ0(t)| = O (‖θ − θ0‖) .
For a single summand in the score,
sup
h∈Hp
E[Sθ1 (h)− Sθ01 (h)]2 = O
(‖θ − θ0‖2) .
We plug θˆ into the expression above. Thus, the variance of the limiting process of
(A27) is o(1) by the consistency of θˆ from Theorem 3’, so the process itself is op(1).
We then show the Fre´chet differentiability of expected score S at θ0 in the direction
of θˆ − θ0,
Sθˆt − Sθ0 = tS˙θ0(θˆ − θ0) + op(t‖θˆ − θ0‖). (A28)
We use a shorthand notation for the expected score at θ:
Sθ(h) = E
[∫ τ ′
0
Kθ1 (h)(u)dM
θ(u) +Kθ2 (h)dM
θ(τ)
]
= E
[∫ τ
0
V θ(h)(u)dMθ(u)
]
,
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by setting
V θ(h)(t) = I(t ≤ τ ′)Kθ1 (h)(t) + I(t = τ)Kθ2 (h).
By the Lipschitz continuity with respect to ‖θ‖ for all terms involved, Kθ1 (h), Kθ2 (h)
and dMθ,
Sθt(h)− Sθ(h)
= E
[∫ τ ′
0
V θt(h)(u)dMθt(u)
]
= E
[∫ τ ′
0
V θ0(h)(u)d
{
Mθt(u)−Mθ0(u)}]+ E [∫ τ ′
0
V θt(h)(u)dMθ0(u)
]
+E
[∫ τ ′
0
{
V θt(h)(u)− V θ0(h)(u)}d{Mθt(u)−Mθ0(u)}]
= tS˙θ0(θ − θ0)(h) + 0 +Op(t2‖θ − θ0‖2).
Again, we plug-in θˆ and use the consistency result to verify the condition (A28).
Afterwards, we find the local inverse of the functional Hessian in (A24). We have
shown in Lemma A2 that the functional operator σ is a continuously invertible bijection
from H∞ to H∞. The invertibility of S˙θ0 in Hp follows from the following argument.
By the continuous invertibility of σ, there is some q so that σ−1(Hq) ⊆ Hp, and
inf
4θ∈linΘ
suph∈Hp |(α−α0)>σa(h) + (β − β0)>σb(h) +
∫ τ ′
0 ση(h)d(Λ− Λ0)|
‖4θ‖l∞(Hp)
≥ inf
4θ∈linΘ
suph∈σ−1(Hq) |(α−α0)>σa(h) + (β − β0)>σb(h) +
∫ τ ′
0 ση(h)d(Λ− Λ0)|
p‖4θ‖
= inf
4θ∈linΘ
suph∈Hq |4θ(h)|
p‖4θ‖ >
q
2p
. (A29)
Finally, let us put everything together. The NPMLE θˆ is shown to be consistent
in Theorem 3’, and (A26), (A27), (A28) and (A29) verify the conditions of Theorem
3.3.1 from Van der Vaart and Wellner (1996).
Proof of Theorem 5. The proof for the continuous invertibility of σˆ is similar to the
proof of Lemma A2. The approximation error between the natural estimator σˆ and
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Louis’ formula variance estimator using (9) again comes from the “ghost copies” like the
case in Lemma 1, so the same argument applies to show their asymptotic equivalence.
B Appendix B: Variance Estimator
B.1 Derivatives of Log-likelihood
Let lc(α,β,λ) =
∑n
i=1 l
c
i (α,β,λ) be the complete data log-likelihood,
lci (α,β,λ) =(Ai +Mi)α
>Z1i − (1 +Mi) log(1 + eα>Z1i)
+ δ1iAi
K∑
k=1
I{Xi = tk}(log λk + β>Z2i)−Ai
∑
k:tk≤Xi
λke
β>Z2i
+Mi
∑
k:tk<Qi
I{κi = k}
(
log λk + β
>Z2i −
k∑
h=1
λhe
β>Z2i
)
.
Its gradient is given by
∇lci =
(
∂lci
∂α
,
∂lci
∂β
,
∂lci
∂λ
)>
,
where
∂lci
∂α
=Z1i
{
Ai +Mi − (1 +Mi) e
α>Z1i
1 + eα>Z1i
}
= Z1i
{
Ai − pi +Mi(1− pi)
}
,
∂lci
∂β
=Z2i
{
Aiδ
1
i +Mi −
(
Ai
∑
k:tk≤Xi
λk +Mi
κi∑
k=1
λk
)
eβ
>Z2i
}
=Z2i
{
Aiδ
1
i +Mi −AiΛi(Xi)−MiΛi(κi)
}
,
∂lci
∂λk
=
(
Aiδ
1
i I{Xi = tk}+MiI{κi = k}
) 1
λk
−
(
AiI{tk ≤ Xi}+MiI{κi ≥ tk}
)
eβ
>Z2i
=Ai
(δ1i I{Xi = tk}
λk
− I{tk ≤ Xi}eβ>Z2i
)
+Mi
(I{κi = k}
λk
− I{κi ≥ tk}eβ>Z2i
)
.
Its Hessian is given by
∇2lci =

∂2lci
∂α∂α> 0 0
0
∂2lci
∂β∂β>
∂2lci
∂β∂λ>
0
[
∂2lci
∂β∂λ>
]>
diag(
∂2lci
∂λ2k
)
 ,
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where
∂2lci
∂α∂α>
=Z1iZ1
>
i
{
− (1 +Mi) e
α>Z1i
(1 + eα>Z1i)2
}
= −Z1iZ1>i (1 +Mi)pi(1− pi),
∂2lci
∂β∂β>
=Z2iZ2
>
i
{
−
(
Ai
∑
k:tk≤Xi
λk +Mi
κi∑
k=1
λk
)
eβ
>Z2i
}
,
∂2lci
∂β∂λk
=Z2i
{
−
(
AiI{tk ≤ Xi}+MiI{tk ≤ κi}
)
eβ
>Z2i
}
,
∂2lci
∂λ2k
=−
(
Aiδ
1
i I{Xi = tk}+MiI{κi = k}
) 1
λ2k
,
∂2lci
∂α∂β>
=
∂2lci
∂α∂λ>
=
∂2lci
∂λk∂λh
= 0, k 6= h.
B.2 Conditional Expectations
By the conditional expectations (5) - (7), we are able to calculate the ‘first order’
conditional expectations, E[∇lci |O] and E[∇2lci |O]:
E
[
∂lci
∂α
]
= Z1i
{
E(Ai)− pi + E(Mi)(1− pi)
}
,
E
[
∂lci
∂β
]
= Z2i
[
E(Ai)
{
δ1i + logSi(Xi)
}
+ E(Mi)
{
1 +
∑
k:tk<Qj
P (T˜ij = tk) logSi(tk)
}]
,
E
[
∂lci
∂λk
]
= E(Ai)
{δ1i I{tk = Xi}
λk
− I{tk ≤ Xi}eβ>Z2i
}
+ E(Mi)
{P (T˜ij = tk)
λk
− P (T˜ij ≥ tk)eβ>Z2i
}
.
E
[
∂2lci
∂α∂α>
]
= −Z1iZ1>i (1 + E(Mi))pi(1− pi),
E
[
∂2lci
∂β∂β>
]
= Z2iZ2
>
i
{
E(Ai) logSi(Xi) + E(Mi)
∑
k:tk<Qi
P (T˜ij = tk) logSi(tk)
}
,
E
[
∂2lci
∂β∂λk
]
= −Z2i
{
E(Ai)I{tk ≤ Xi}+ E(Mi)P (tk ≤ κi)
}
eβ
>Z2i ,
E
[
∂2lci
∂λ2k
]
= −
{
E(Ai)δ
1
i I{T˜ij = tk}+ E(Mi)P (T˜ij = tk)
} 1
λ2k
.
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To calculate ‘second order’ expectation E[∇lci∇lci>|O], we first compute the conditional
variances:
Var[Ai|O] = δci
pi(1− pi)Si(Xi){
1− pi + piSi(Xi)
}2 ,
Var[Mi|O] =
pi
[
1− Si(Qi)
}
{
1− pi + piSi(Qi)
}2 .
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Then,
E
[
∂lci
∂α
∂lci
∂α
>]
=E
[
∂lci
∂α
]
E
[
∂lci
∂α
]>
+ Z1iZ1
>
i
{
(1− pi)2Var(Mi) + Var(Ai)
}
,
E
[
∂lci
∂α
∂lci
∂β
>]
=E
[
∂lci
∂α
]
E
[
∂lci
∂β
]>
+ Z1iZ2
>
i
[
Var(Ai)
{
δ1i + logSi(Xi)
}
+ Var(Mi)(1− pi)
{
1 +
∑
k:tk<Qi
P (T˜ij = tk) logSi(tk)
}]
,
E
[
∂lci
∂β
∂lci
∂β
>]
=E
[
∂lci
∂β
]
E
[
∂lci
∂β
]>
+ Z2iZ2
>
i
[
Var(Ai)
{
δ1i + logSi(Xi)
}2
+ Var(Mi)
{
1 +
∑
k:tk<Qi
P (T˜ij = tk) logSi(tk)
}2
+ E(Mi)
{ ∑
k:tk<Qi
P (T˜ij = tk) logSi(tk)
2 − ( ∑
k:tk<Qi
P (T˜ij = tk) logSi(tk)
)2}]
,
E
[
∂lci
∂α
∂lci
∂λk
]
=E
[
∂lci
∂α
]
E
[
∂lci
∂λk
]
+ Z1i
[
Var(Ai)
{δ1i I{tk = Xi}
λk
− I{tk ≤ Xi}eβ>Z2i
}
+ Var(Mi)(1− pi)
{P (T˜ij = tk)
λk
− P (T˜ij ≥ tk)eβ>Z2i
}]
,
E
[
∂lci
∂β
∂lci
∂λk
]
=E
[
∂lci
∂β
]
E
[
∂lci
∂λk
]
+ Z2i
[
Var(Ai)
{
δ1i + logSi(Xi)
}{δ1i I{tk = Xi}
λk
− I{tk ≤ Xi}eβ>Z2i
}
+ Var(Mi)
{P (T˜ij = tk)
λk
− P (T˜ij ≥ tk)eβ>Z2i
}{
1 +
∑
h:th<Qi
P (T˜ij = th) logSi(th)
}
− E(Mi)
{ ∑
h:th<Qi
P (T˜ij = th) logSi(th)
P (T˜ij = tk)
λk
− P (T˜ij = tk) logSi(tk)
λk
− P{T˜ij ≥ tk}eβ>Z2i
∑
h:th<Qi
P (T˜ij = th) logSi(th)
+ eβ
>Z2i
th<Qi∑
h=k
P (T˜ij = th) logSi(th)
}]
,
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E[
∂lci
∂λk
∂lci
∂λh
]
= EAi
{
−δ
1
i I{Xi = tk∨h}
λk∨h
eβ
>Z2i + I{Xi ≥ tk∨h}e2β>Z2i
}
+ E(Ai)E(Mi)
{
δ1i I{T˜ij = tk}
λk
− I{Xi ≥ tk}eβ>Z2i
}{
P (T˜ij = th)
λh
− P (T˜ij ≥ th)eβ>Z2i
}
+ E(Ai)E(Mi)
{
δ1i I{Xi = th}
λh
− I{Xi ≥ th}eβ>Z2i
}{
P (T˜ij = tk)
λk
− P (T˜ij ≥ tk)eβ>Z2i
}
+ E[M2i −Mi]
{
P (T˜ij = tk)
λk
− P (T˜ij ≥ tk)eβ>Z2i
}{
P (T˜ij = th)
λh
− P (T˜ij ≥ th)eβ>Z2i
}
+ E(Mi)
{
−P (T˜ij = tk∨h)
λk∨h
eβ
>Z2i + P (κi ≥ tk∨h)e2β>Z2i
}
,
E
[
∂lci
∂λk
∂lci
∂λk
]
= EAi
{
δ1i I{T˜ij = tk}
λk
− I{Xi ≥ tk}eβ>Z2i
}2
+ E(Ai)E(Mi)
{
δ1i I{T˜ij = tk}
λk
− I{Xi ≥ tk}eβ>Z2i
}{
P (T˜ij = tk)
λk
− P (T˜ij ≥ tk)eβ>Z2i
}
+ E(Ai)E(Mi)
{
δ1i I{T˜ij = tk}
λk
− I{Xi ≥ tk}eβ>Z2i
}{
P (T˜ij = tk)
λk
− P (T˜ij ≥ tk)eβ>Z2i
}
+ E[M2i −Mi]
{
P (T˜ij = tk)
λk
− P (T˜ij ≥ tk)eβ>Z2i
}{
P (T˜ij = tk)
λk
− P (T˜ij ≥ tk)eβ>Z2i
}
+ E(Mi)
{
P (T˜ij = tk)
λ2k
− 2P (T˜ij = tk)
λk
eβ
>Z2i + P (T˜ij ≥ tk)e2β>Z2i
}
.
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Figure 1: Study entry times for all individuals in the SAB data (left), and left truncated
Kaplan-Meier curves (95% confidence intervals) for the SAB events (right).
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Table 1: Simulation results using the EM algorithm for NPMLE.
n = 200 n = 1000
True Value Estimate Sample SD SE Coverage Estimate Sample SD SE Coverage
10% Truncation, 0% Censoring
α0 1.00 1.01 0.79 0.75 94.0 % 0.98 0.35 0.33 93.6 %
α1 -0.63 -0.64 0.20 0.19 94.8 % -0.63 0.09 0.08 94.3 %
α2 1.00 1.00 0.36 0.37 95.6 % 1.01 0.16 0.16 94.8 %
β1 -0.20 -0.23 0.20 0.17 92.2 % -0.20 0.07 0.07 95.6 %
β2 0.30 0.33 0.34 0.32 94.2 % 0.29 0.14 0.13 93.4 %
20% Truncation, 0% Censoring
α0 1.00 0.97 0.80 0.79 94.8 % 0.99 0.34 0.35 96.0 %
α1 -0.63 -0.64 0.21 0.20 95.4 % -0.63 0.09 0.09 96.2 %
α2 1.00 0.98 0.40 0.39 95.4 % 0.99 0.17 0.17 95.2 %
β1 -0.20 -0.20 0.20 0.18 94.6 % -0.20 0.07 0.07 95.2 %
β2 0.30 0.31 0.37 0.34 94.6 % 0.30 0.14 0.14 94.2 %
10% Truncation, 20% Censoring
α0 1.00 1.18 0.97 0.99 96.6 % 1.02 0.41 0.42 95.8 %
α1 -0.63 -0.69 0.25 0.26 96.2 % -0.64 0.11 0.11 96.2 %
α2 1.00 1.01 0.50 0.49 95.4 % 1.00 0.20 0.21 96.0 %
β1 -0.20 -0.21 0.30 0.26 91.6 % -0.21 0.11 0.11 94.4 %
β2 0.30 0.31 0.53 0.49 93.4 % 0.30 0.21 0.20 93.8 %
20% Truncation, 20% Censoring
α0 1.00 1.05 1.00 0.96 95.8 % 0.98 0.37 0.41 97.0 %
α1 -0.63 -0.66 0.27 0.25 96.6 % -0.63 0.10 0.11 96.6 %
α2 1.00 1.05 0.49 0.47 95.6 % 1.01 0.20 0.20 94.6 %
β1 -0.20 -0.19 0.30 0.26 90.4 % -0.20 0.11 0.11 95.0 %
β2 0.30 0.33 0.54 0.48 92.2 % 0.31 0.21 0.20 94.8 %
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Table 2: Cure rate model versus naive model fits for SAB data
Cure model Separate models
Estimate (SE) P-value Estimate (SE) P-value
Logistic
Intercept -0.74 (0.54) 0.17 -2.25 (0.49) <0.01
Healthy -0.54 (0.49) 0.27 -0.92 (0.45) 0.04
Diseased Control 0.18 (0.31) 0.56 0.01 (0.28) 0.98
BMI -0.37 (0.18) 0.04 -0.11 (0.16) 0.51
Gravidity>1 0.01 (0.3) 0.97 0.2 (0.27) 0.46
Smoking 0.41 (0.37) 0.27 0.65 (0.34) 0.06
Alcohol -0.1 (0.29) 0.73 -0.24 (0.26) 0.35
Cox PH
Healthy Control -0.36 (0.38) 0.34 -0.41 (0.5) 0.42
Diseased Control -0.34 (0.25) 0.17 -0.29 (0.32) 0.36
BMI -0.35 (0.09) <0.01 -0.84 (0.22) <0.01
Gravidity>1 -0.52 (0.23) 0.02 -0.38 (0.28) 0.18
Smoking -1.01 (0.33) <0.01 -0.65 (0.36) 0.08
Alcohol 0.66 (0.26) 0.01 0.87 (0.29) <0.01
47
Figure 2: Left truncated Kaplan-Meier curves for SAB events according to BMI (top) or
alcohol (bottom), among the full data set (left) and without the observed cured individuals
(right); the p-values are from the cure model (Table 2).
0 5 10 15 20
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
Weeks in Gestation
SA
B 
Pr
ob
ab
ilit
ie
s
BMI < 25
BMI >= 25 p−value: 0.04
0 5 10 15 20
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
Weeks in Gestation
SA
B 
Pr
ob
ab
ilit
ie
s
BMI < 25
BMI >= 25
p−value: <0.01
0 5 10 15 20
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
Weeks in Gestation
SA
B 
Pr
ob
ab
ilit
ie
s
No Alcohol
Alcohol p−value: 0.73
0 5 10 15 20
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
Weeks in Gestation
SA
B 
Pr
ob
ab
ilit
ie
s
No Alcohol
Alcohol
p−value: 0.01
48
